Publication:
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By